PubRank

F Bridey

Author PubWeight™ 19.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992 2.31
2 Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients. J Thromb Haemost 2007 1.69
3 Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives. Thromb Haemost 1995 1.59
4 Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 1995 1.58
5 Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods. J Thromb Haemost 2005 1.06
6 Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med 1991 1.02
7 Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes. FEBS Lett 1993 0.92
8 Activation of coagulation and fibrinolysis in heatstroke. Thromb Haemost 1996 0.92
9 Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study. Circulation 1992 0.88
10 Effect of advanced glycation end product-modified albumin on tissue factor expression by monocytes. Role of oxidant stress and protein tyrosine kinase activation. Arterioscler Thromb Vasc Biol 1997 0.88
11 Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin. Am J Hematol 1996 0.85
12 Interleukin-10 and pentoxifylline inhibit C-reactive protein-induced tissue factor gene expression in peripheral human blood monocytes. FEBS Lett 1994 0.82
13 Treatment of inherited protein C deficiency by replacement therapy with the French purified plasma-derived protein C concentrate (PROTEXEL). Vox Sang 2007 0.80
14 Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven®, a factor XI concentrate. Haemophilia 2011 0.80
15 Accuracy of two wavelength pulse oximetry in neonates and infants. Pediatr Pulmonol 1989 0.79
16 Anti-vascular endothelial cell antibodies (AECA): comparison of two assay methods and clinical applications. Rev Rhum Engl Ed 1995 0.79
17 A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate. Thromb Haemost 1998 0.78
18 Prevalence of antiphospholipid-related antibodies in unselected patients with history of venous thrombosis. Blood Coagul Fibrinolysis 1998 0.77
19 Treatment of severe venous thrombo-embolism with intravenous Hirudin (HBW 023): an open pilot study. Thromb Haemost 1993 0.76
20 High familial anticardiolipin antibody titer and major histocompatibility complex. Thromb Haemost 1996 0.75
21 [A new cause of acute avitaminosis K: lamoxactam]. Gastroenterol Clin Biol 1983 0.75
22 Lupus anticoagulant and HIV infection: a prospective study. AIDS 1990 0.75
23 [Myocardial infarction and multiple thrombosis complicating heparin-induced thrombopenia]. Presse Med 1987 0.75
24 [A sickle cell homozygote with transfusion deadlock. Favorable outcome with hydroxyurea treatment]. Rev Fr Transfus Hemobiol 1993 0.75
25 Accuracy of measurements of HbF with OSM3 in neonates and infants. Eur Respir J 1992 0.75
26 [Monitoring heparin therapy (author's transl)]. Ann Pharm Fr 1978 0.75
27 Priapism revealing ARG 506 to GLN factor V mutation. J Urol 1996 0.75
28 Gender difference in factor VII and in activated factor VII levels in unstable angina. Thromb Haemost 1996 0.75
29 [Therapeutic approach to pulmonary embolism]. J Mal Vasc 1989 0.75
30 [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique]. Presse Med 1995 0.75
31 In vivo effect of Echis carinatus venom observed in a woman in Mali. Thromb Haemost 1993 0.75
32 Prenatal diagnosis in type IIA von Willebrand disease. Nouv Rev Fr Hematol 1990 0.75